Audited Results of Anthem Biosciences Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	2,089.31	1,840.65	1,417.54	1,056.92	1,231.26
Manufacturing Expenses	1.21	42.56	31.29	38.95	36.32
Personnel Expenses	263.92	252.17	182.65	153.24	137.51
Selling Expenses	1.21	1.56	1.06	0.54	0.12
Administrative Expenses	176.41	113.98	98.11	95.87	82.93
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,238.19	1,151.64	912.65	627.87	665.80
Operating Profit	851.12	689.01	504.89	429.06	565.45
Other Recurring Income	182.07	109.44	70.52	77.37	48.98
Adjusted PBDIT	1,033.19	798.45	575.41	506.43	614.43
Financial Expenses	6.55	9.09	9.14	6.75	10.09
Depreciation	99.56	77.94	81.49	63.70	57.76
Other Write offs	0	0	0	0	0
Adjusted PBT	927.08	711.42	484.77	435.98	546.59
Tax Charges	232.51	205.24	109.99	112.11	140.60
Adjusted PAT	694.58	506.19	374.78	323.87	405.99
Non Recurring Items	-24.01	0	0	61.80	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	670.56	506.19	374.78	385.67	405.99
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	2,650.28	2,030.34	1,595.80	1,259.54	1,015.25

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article